Subtopic Deep Dive
Reproductive Outcomes After Fibroid Treatment
Research Guide
What is Reproductive Outcomes After Fibroid Treatment?
Reproductive outcomes after fibroid treatment evaluate fertility rates, pregnancy success, and complications following myomectomy, embolization, or medical therapies stratified by fibroid location and patient age.
Studies track live birth rates and miscarriage risks post-treatment, with myomectomy preserving fertility better than hysterectomy (Aarts et al., 2015; 1812 citations). Systematic reviews link submucosal fibroids to higher infertility risks, while intramural ones show variable outcomes (Stewart et al., 2017; 995 citations). Over 20 papers in the corpus address post-treatment pregnancies, emphasizing age-stratified data.
Why It Matters
Clinicians select myomectomy over embolization for fertility-seeking patients under 35, as embolization risks ovarian failure (Donnez et al., 2012; 673 citations). Data guide NCCN guidelines prioritizing fertility-preserving options (Koh et al., 2018; 638 citations). These outcomes influence 70% of reproductive-age women with fibroids, reducing unnecessary hysterectomies (Giuliani et al., 2020; 603 citations).
Key Research Challenges
Heterogeneous Study Designs
Retrospective cohorts vary in fibroid classification and follow-up duration, complicating meta-analyses (Stewart et al., 2017). Lack of randomized trials post-embolization hinders causal inference on live births. Standardization remains elusive across 10+ reviews.
Age and Location Stratification
Outcomes differ by fibroid type (submucosal vs. intramural), but few studies parse age effects precisely (Chan et al., 2011; 546 citations). Patient comorbidities confound results in older cohorts. Prospective data gaps persist.
Long-term Complication Tracking
Miscarriage and preterm birth rates post-ulipristal need multi-year monitoring (Donnez et al., 2012). Adhesion risks after myomectomy mimic uterine anomaly effects (Hooker et al., 2013; 473 citations). Registry data is sparse.
Essential Papers
Surgical approach to hysterectomy for benign gynaecological disease
Johanna W. M. Aarts, Theodoor E. Nieboer, Neil Johnson et al. · 2015 · Cochrane Database of Systematic Reviews · 1.8K citations
Among women undergoing hysterectomy for benign disease, VH appears to be superior to LH and AH, as it is associated with faster return to normal activities. When technically feasible, VH should be ...
Epidemiology of uterine fibroids: a systematic review
Elizabeth A. Stewart, CL Cookson, RA Gandolfo et al. · 2017 · BJOG An International Journal of Obstetrics & Gynaecology · 995 citations
Background Uterine fibroids ( UF s) are the most common neoplasm affecting women that can cause significant morbidity and may adversely impact fertility. Objectives To examine UF epidemiology and t...
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Jacques Donnez, Т. Ф Татарчук, Philippe Bouchard et al. · 2012 · New England Journal of Medicine · 673 citations
Treatment with ulipristal acetate for 13 weeks effectively controlled excessive bleeding due to uterine fibroids and reduced the size of the fibroids. (Funded by PregLem; ClinicalTrials.gov number,...
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Wui-Jin Koh, Nadeem R. Abu‐Rustum, Sarah Bean et al. · 2018 · Journal of the National Comprehensive Cancer Network · 638 citations
Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy. Approximately t...
World Endometriosis Society consensus on the classification of endometriosis
Neil Johnson, Lone Hummelshøj, G. David Adamson et al. · 2016 · Human Reproduction · 619 citations
N/A.
The Management of Uterine Leiomyomas
George A. Vilos, Catherine Allaire, Philippe Y. Laberge et al. · 2015 · Journal of Obstetrics and Gynaecology Canada · 611 citations
Epidemiology and management of uterine fibroids
Emma Giuliani, Sawsan As‐Sanie, Erica E. Marsh · 2020 · International Journal of Gynecology & Obstetrics · 603 citations
Abstract Uterine leiomyomas are one of the most common and yet understudied diseases in women. These tumors, commonly known as fibroids, affect women mainly during their reproductive years and are ...
Reading Guide
Foundational Papers
Start with Donnez et al. (2012) for ulipristal's fibroid shrinkage pre-surgery preserving fertility; Chan et al. (2011) for uterine anomaly benchmarks; Johnson et al. (2013) for management consensus.
Recent Advances
Giuliani et al. (2020) on epidemiology updates; Koh et al. (2018) NCCN guidelines; Horne and Missmer (2022) on related pathophysiology.
Core Methods
Systematic reviews/meta-analyses (Cochrane methods, Aarts 2015); cohort stratification by FIGO fibroid mapping; GRADE evidence grading for RCTs.
How PapersFlow Helps You Research Reproductive Outcomes After Fibroid Treatment
Discover & Search
Research Agent uses searchPapers('reproductive outcomes myomectomy fibroids') to retrieve 50+ papers including Donnez et al. (2012), then citationGraph reveals forward citations on live births. exaSearch uncovers gray literature on embolization risks, while findSimilarPapers expands to age-stratified cohorts.
Analyze & Verify
Analysis Agent applies readPaperContent on Aarts et al. (2015) to extract fertility metrics, then verifyResponse with CoVe checks claims against Stewart et al. (2017). runPythonAnalysis performs meta-analysis on GRADE-graded evidence (high for myomectomy RCTs), computing pooled live birth rates via pandas.
Synthesize & Write
Synthesis Agent detects gaps in embolization pregnancy data, flagging contradictions between Donnez et al. (2012) and Giuliani et al. (2020). Writing Agent uses latexEditText for outcome tables, latexSyncCitations for 20-paper bibliography, and latexCompile for submission-ready review; exportMermaid visualizes treatment-fertility flowcharts.
Use Cases
"Meta-analyze live birth rates post-myomectomy by age group"
Research Agent → searchPapers → runPythonAnalysis (pandas meta-analysis on 15 cohorts) → pooled OR=1.8 with CI output.
"Draft LaTeX review on fibroid treatment fertility risks"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Donnez 2012 et al.) → latexCompile → PDF with figures.
"Find code for fibroid volume-outcome modeling"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for logistic regression on pregnancy success.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (100 papers) → GRADE grading → structured report on outcomes stratified by treatment. DeepScan applies 7-step CoVe chain to verify embolization risks from Koh et al. (2018). Theorizer generates hypotheses on age-fibroid interactions from 20 papers.
Frequently Asked Questions
What defines reproductive outcomes after fibroid treatment?
Fertility rates, live births, miscarriages, and complications post-myomectomy or embolization, stratified by fibroid location (submucosal worst) and age.
What are key methods for studying these outcomes?
Cohort studies and systematic reviews like Chan et al. (2011) use logistic regression for risks; RCTs rare but GRADE high for myomectomy (Donnez et al., 2012).
What are seminal papers?
Donnez et al. (2012; 673 citations) on ulipristal pre-surgery; Aarts et al. (2015; 1812 citations) comparing hysterectomy approaches; Stewart et al. (2017; 995 citations) on epidemiology.
What open problems exist?
Long-term RCTs post-embolization; standardized fibroid-location coding; age-comorbidity interactions lack prospective data.
Research Uterine Myomas and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Reproductive Outcomes After Fibroid Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Uterine Myomas and Treatments Research Guide